SUBSCRIBERS
Medtech startup set to revolutionise cancer diagnostics
Published Wed, Jan 21, 2015 · 09:50 PM
Singapore
A SINGAPORE-based medtech startup that is looking to bring low-cost, simple-to-use cancer diagnostics tests to the masses, is set to revolutionise the global cancer diagnostics market that is projected to hit some US$168.6 billion in 2020.
VolitionRx h…
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Consumer & Healthcare
Abbott beats quarterly profit estimates on strong medical device sales
Adidas shares surpass two-year high as 'terrace' sneaker trend boosts brand heat
LVMH’s first quarter sales growth slips to 3% on luxury slowdown
US Justice Department to file antitrust suit against Live Nation: WSJ
EU set to launch China probe on medical device procurement
Muji bets its minimalist retail will work for homes, hotels